Todd E. Golde on Aducanumab Still Needs to Prove Itself, Researchers Say
COMMENT I agree with published studies by Knopman and Schneider and colleagues that the current aducanumab trials fail to prove efficacy. I am worried that many stakeholders with good intentions are trying to push this forward, but this is a dangerous path. We ...